VERTEX PHARMACEUTICALS INC / MA (VRTX)
About VERTEX PHARMACEUTICALS INC / MA
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $12.0B
- Net income
- $4.0B
- Total assets
- $25.6B
- Market cap
- $121.2B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $121.2B
- Shares outstanding
- 234.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 31, 1991
Vertex Pharmaceuticals Inc / MA (VRTX) Stock Price
- Profitable — net income of $4.0B in FY2025.
- Trading 7% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review VERTEX PHARMACEUTICALS INC / MA.
Write a review
News about VERTEX PHARMACEUTICALS INC / MA
News & sentiment via Polygon.io
Vertex Pharmaceuticals Inc / MA: frequently asked questions
Is Vertex Pharmaceuticals Inc / MA an American company?
Vertex Pharmaceuticals Inc / MA is a US-based company headquartered in Boston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Vertex Pharmaceuticals Inc / MA headquartered?
Vertex Pharmaceuticals Inc / MA is headquartered in Boston, Massachusetts, United States.
Is Vertex Pharmaceuticals Inc / MA publicly traded?
Yes — Vertex Pharmaceuticals Inc / MA is a publicly traded company. Its stock trades under the ticker symbol VRTX on the NASDAQ.
What does Vertex Pharmaceuticals Inc / MA do?
Vertex Pharmaceuticals Inc / MA is an American Pharmaceuticals company in the Health & Beauty sector.
